Breakout 4.2 Optimise not maximise for better value COPD and asthma care - Noel Baxter

1

Noel Baxter GP

Co-lead NHS London Respiratory Team

Optimise not maximise for

better value COPD & asthma

care

The VALUE equation

Health

Outcomes Patient defined

bundle of care

Cost Value =

Health Outcomes

Cost of delivering

Outcomes

Porter ME; Lee TH NEJM 2010;363:2477-2481; 2481-2483

2

We know what interventions are good value –

when they are done in the right way

Triple Therapy

£35,000-£187,000/QALY

LABA

£8,000/QALY

Tiotropium

£7,000/QALY

Pulmonary Rehabilitation

£2,000-8,000/QALY

Stop Smoking Support with pharmacotherapy £2,000/QALY

Flu vaccination £1,000/QALY in “at risk” population

1 year abstinence

%

QALY

£

Usual care 1.4

Minimal counselling 2.6 14,735

Intensive counselling 6 7,149

Intensive counselling +

pharmacotherapy

12.3 2,092

Systematic Review of 9 studies Hoogendoorn M, Feenstra TL, Hoogenveen RT, Rutten-van Mo¨lken MPMH. Thorax 2010: 65:711-718

A cost effective intervention in COPD - Stopping Smoking

What works long term and is cost effective?

3

The low value pyramid

We know how to allocate resource at

population level http://www.impressresp.com/index.php?option=com_content&view=article&id=167:impressions-28-relative-value-of-copd-interventions&catid=11:impressions&Itemid=3

4

COPD in London: What do we know?

Londoners dying from smoking

‘1 in 5 deaths due to

smoking’

5

Stop smoking support: Step 1 treatment for

people with asthma who smoke and for

households of children with asthma that

smoke

“ 32.5% of patients admitted to hospital were current smokers …a further 18.8% were ex‐smokers …a significantly greater number of asthmatics reported themselves to be smokers over the general population … … smoking causes steroid resistance in asthma and is associated with other ‘risk’ behaviours, which may make this group more likely to be admitted to hospital

Optimal healthcare for up to 1:4 people with a

long term condition is stop smoking support as

treatment

6

Admissions ( asthma and COPD) : What factors

can we influence as health professionals ?

• Bed capacity

• Distance to hospital

• Deprivation of population

• Socioeconomic status

• Prevalence of COPD

• Prevalence of smoking in our practices

Where can we make an impact for people

with COPD and asthma ?

• For every 1% increase in prevalence of

smoking in your COPD population there is a

1% increase in COPD admission rates.

• For every 1% increase in prevalence of

smoking in your asthma population there is a

1% increase in asthma admission rates.

7

8

PCT monthly COPD dashboard 2013

Prevalence of current

smoking where status

recorded in last 15 months

1550/3335 = 46.5%

COPD smokers in last year receiving evidence based stop smoking

support – 17.5%

Quit smoking as treatment Sharing Whittington learning

Health professionals esp doctors need to believe quit smoking

interventions are part of their role & responsibility

Behaviour change: importance, confidence

Make it easy to do

clinical leadership, systems & incentives

• Brief interventions

• Behaviour change skills

• Knowledge of quit smoking services & referral

• Prescribing knowledge & medications available

• Measure outcomes and provide feedback

• Acute Trust and Mental Health Trust CQINs

9

10

Are your hospital staff able, & confident

to, prescribe Quit Smoking medication?

Does your hospital provide nicotine

replacement therapy routinely on

admission for smokers?

How do we make this happen?

11

What did we do?

More about LRT and Right Care @ www.londonrespiratoryteamconference.com

12